ERBB2 and neoplasm: Similar to the study of Desmedt et al., this study also showed TILs were associated with younger age, larger tumor size, lymph node involvement, poor Nottingham prognostic index, HER2 amplification, prominent nucleoli as well as poor overall survival and invasive disease-free survival.